Position in DYN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,386,176
+$6,651,245 QoQ
Shares Held
1,278,081
+6.6% QoQ
Ownership
0.684%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. DYN ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,386,176 | 1,278,081 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $21,734,931 | 1,198,838 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $21,363,253 | 1,092,191 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $13,125,232 | 1,037,568 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,006,668 | 841,037 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $7,556,949 | 722,462 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18,306,423 | 777,013 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $25,916,350 | 721,502 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $21,867,059 | 619,639 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $15,530,321 | 547,035 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,627,029 | 423,085 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,532,487 | 394,251 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,285,439 | 380,928 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,161,927 | 274,473 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,257,194 | 281,035 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,385,577 | 266,581 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,827,680 | 266,038 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,474,240 | 256,664 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,106,083 | 261,235 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $4,177,122 | 257,212 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,685,659 | 270,231 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,724,659 | 175,445 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,408,510 | 162,310 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||